Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SM-13496 in Bipolar I Depression
NCT01986101Phase 3Completed
- Sponsor
- Sumitomo Pharma
- Start
- Feb 2014
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of lurasidone in bipolar I disorder, sponsored by Sumitomo Pharma. Started Feb 2014; status: completed.
02
Drugs
lurasidone
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT01986101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01986101.